Table 3.
Univariate Hazard Ratio (95% Confidence Interval) |
p-Value | |
---|---|---|
Age (per year) | 1.04 (1.01–1.08) | 0.0093 |
Male sex | 2.71 (1.00–8.00) | 0.051 |
WHO grade | 3.64 (1.63–9.63) | 0.0010 |
Genetic status | NA | <0.0001 |
TNR | 1.34 (0.86–2.03) | 0.19 |
MTV | 1.01 (1.00–1.02) | 0.086 |
TLMU | 1.00 (1.00–1.01) | 0.11 |
Dissimilarity | 0.93 (0.77–1.09) | 0.37 |
LGRE | 2.30 × 1011 (737.11–4.23 × 1019) | 0.0096 |
HGRE | 1.00 (0.99–1.00) | 0.11 |
GLNUr | 1.00 (1.00–1.00) | 0.27 |
Correlation | 5.17 (1.07–20.93) | 0.041 |
Entropy | 0.77 (0.44–1.57) | 0.45 |
WHO, World Health Organization; NA, not available because patients with IDH mutations and 1p/19q-codeleted had no events during the follow-up; TNR, tumor-to-normal ratio; MTV, metabolic tumor volume; TLMU, total legion methionine uptake; LGRE, low gray-level run emphasis; HGRE, high gray-level run emphasis; GLNUr, gray-level non-uniformity for run.